Objectives: Faster recovery of postexertional dyspnea might enable chronic obstructive pulmonary disease (COPD) patients to undertake more physical activity.
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity worldwide and is expected to become the third most common cause of death by 2030 (Mathers & Loncar, 2006) . The pathological changes in the lung lead to breathlessness and an understandable disinclination to exercise, which results in a vicious circle of inactivity and reduced cardiovascular fitness such that physical inactivity is a key predictor of mortality in COPD (Waschki et al., 2011) . Although the condition is incurable, a recent comprehensive meta-analysis (McCarthy et al., 2015) has shown that pulmonary rehabilitation relieves dyspnea and fatigue and enhances the sense of control that individuals have over their condition. The outcomes of rehabilitation programmes consisting of exercise alone give comparable results to those with more complex interventions (McCarthy et al., 2015) and within sensible limits the benefits of exercise increase with the volume of training. However, for many COPD patients, exercise involves progressive air trapping as a result of damage to the structure of the airways, leading to dynamic hyperinflation (O'Donnell, 1994; O'Donnell & Webb, 2008; Viegi et al., 2007) . Breathing at high lung volume involves a greater mechanical load and increased respiratory drive, which results in dyspnea O'Donnell, 1994) and may limit the success of pulmonary rehabilitation.
Air trapping can be prevented, reduced, or reversed by maintaining a positive expiratory pressure (PEP; O'Donnell, 1994; PuenteMaestu & Stringer, 2006) , but PEP devices tend to be cumbersome to use during exercise and the added expiratory resistance can make the work of breathing more difficult (van der Schans et al., 1994) , particularly when using threshold pressure devices.
Most types of daily physical activity involve intermittent periods of exercise and rest and for COPD patients the rest intervals are understandably longer than for healthy individuals. Speeding recovery and shortening the rest intervals could be an effective way of increasing the total physical activity of COPD patients during pulmonary rehabilitation, or at home or work. Only one study, by Martin and Davenport (2011) , has examined the effects of PEP breathing on the rate of recovery, showing that exhaling against a pressure of 10-cm H 2 O for six breaths reduced dyspnea following 6-min submaximal treadmill walking with COPD patients.
Because the rationale for using PEP is to reduce hyperinflation, it is natural to assume that it will only benefit patients with lung hyperinflation, and thus, van der Schans et al. (1994) selected only such patients for their study. Martin and Davenport (2011) did not measure inspiratory capacity (IC), so it is not clear whether their subjects had lung hyperinflation. If a PEP device is to be offered to patients, it would be important to know whether it is necessary to first identify them as patients with or without lung hyperinflation, as van der Schans et al. (1994) did, and prescribe PEP use accordingly.
The main objective of this study was to determine whether PEP breathing can shorten recovery time after exercise such as during pulmonary rehabilitation of COPD patients. The secondary objective was to determine whether the benefits of PEP are limited to patients showing substantial dynamic hyperinflation.
| METHODS

| Participants
Participants were recruited by the physiotherapist from among patients with established COPD attending follow-up clinics of the University Hospital. Inclusion criteria were forced expiratory volume in 1 s (FEV 1 )/forced vital capacity (FVC) < 70% and moderate to severe COPD (FEV 1 30-79% predicted), clinically stable and free of exacerbations. Exclusion criteria were age over 70 years, cardiovascular disease, any musculoskeletal problems that limited exercise, neurological or cognitive impairment, or psychiatric illness. Most of the participants had received some form of pulmonary rehabilitation but not within the last 6 months.
Thirteen patients gave their informed consent in writing to the study which was approved by the University Ethical Committee, and their characteristics and baseline measurements are summarized in Table 1 . None used supplemental oxygen or reported dyspnea at rest.
Medications used were Theodur and Seretide together with Ventolin or Beradual.
This study was a prospective crossover trial with a balanced design and random allocation and has been registered as a clinical trial.
ID: NCT 02398071.
| Exercise
Patients marched on the spot at a self-selected speed. The patient marched, lifting the knees to give a hip flexion of about 70°, and with arms swinging up the horizontal, using a marker on the wall at shoulder height as a target (Figure 1 ). Throughout the exercise, the patients were reminded of the targets for the arms and knee. The speed was established by asking the patients to march as fast as they comfortably could, and the stepping frequency adopted at the first visit was recorded, and a metronome was used to set the same speed on subsequent visits. Patients were advised that they could stop any time when the exercise became unpleasant or continue until 5 min.
At the end of exercise, patients sat and undertook the interventions, consisting of six breaths though a mouthpiece attached to the PEP device (BreatheMAX, C&D Biomedical, Thailand), which also allowed pressure and flow to be monitored ( Figure 2 ). They remained seated for the remainder of the 10-min recovery period. 
| PEP and Sham interventions
| Respiratory function
Oxygen saturation (SpO 2 ) was measured with a finger pulse oximeter.
End tidal pressure of carbon dioxide (P ET CO 2 ) was measured via a nasal cannula at rest, during exercise and recovery, or from a side 
| Rating of dyspnea
Patients rated their dyspnea at rest and every minute throughout exercise and recovery using the Modified Borg CR10 scale from 0 to10, with verbal descriptions of commonly used terms of breathless sensation, where 0 corresponds to absence of dyspnea and 10 corresponds to a "very, very severe" sensation (Borg, 1982; Mahler & Horowitz, 1994) . Patients simply pointed at the appropriate point on the scale so as not to disrupt the exercise.
| Study protocol
For the main study, there were three visits to the laboratory separated by at least 2 days.
The first visit was to determine the extent to which each patient developed hyperinflation as a result of the exercise. The second visit assessed the effectiveness of the interventions in reducing the hyperinflation, whereas the third visit assessed the effect of the interventions on recovery of breathlessness.
The flow of patients and sequence of tests are shown in Figure 3 .
Each visit began with the participant using a bronchodilator followed by 30-min seated rest.
| Visit 1
The participants were familiarized with the various outcome measurements, the marching exercise, and practiced breathing according to the Sham and PEP intervention. After resting for at least 30 min, the patients exercised for 5 min of marching. Dyspnea and cardiorespiratory measures were assessed at baseline and every minute during 
| Visit 3
The procedure was identical to Visit 2 except SVC was measured at rest and then only after 10-min recovery. Dyspnea and other outcome measures were assessed every minute during the recovery.
| Visit 4
Subsequently, 10 patients agreed to pay a fourth visit to the laboratory. This Control visit was the same as Visit 3 except there was no intervention with just dyspnea and cardiorespiratory measures recorded every minute during the exercise and for 10-min recovery.
These data are discussed here but were not included in any of the statistical analyses because it was not part of the randomization procedure.
| Data analysis
Data for heart rate, P ET CO 2 , SpO 2 , and respiratory rate were analysed by two-way repeated measures analysis of variance and post hoc 
| RESULTS
All participants were able to exercise for 5 min, choosing a frequency of around 100 steps per minute, and experienced no adverse events.
In total, each participant undertook five or six trials with the heart rate and dyspnea responses to the exercise portion being very con- At the end of exercise, heart rate was approximately 70% of the age-predicted maximum, fell rapidly in the first 2-to 3-min recovery and then more slowly towards resting values by 10 min, with little difference between conditions.
Respiratory rate increased during exercise, fell during the PEP and Sham interventions (since participants were instructed to breathe slowly), increased, and then returned to resting levels within 2-to 3-min of recovery (Figure 4b ). There were no differences between PEP and Sham interventions.
Oxygen saturation dropped to 95% by the second minute of exercise and remained constant until the end (Figure 4c ), returning FIGURE 3 Flow of patients and sequence of tests. Visits to the laboratory were separated by at least 2 days. Visit 4 was 2-3 weeks after Visit 3 and was not part of the randomized trial (see Section 2). COPD: chronic obstructive pulmonary disease rapidly to levels slightly higher than resting, and with no differences between conditions. P ET CO 2 increased in the first 2 min and remained constant until The present results show that PEP breathing, reducing recovery time, could be a useful addition to an exercise programme allowing more repetitions in a session. The knowledge that the symptoms of dyspnea can be controlled with a relatively simple device may also reassure the patient making him, or her, more confident about undertaking physical activity.
The data confirm a previous observation that PEP breathing significantly speeds the recovery of dyspnea following exercise, and we have extended this to spot marching. This rehabilitation exercise, which includes arm movements, was convenient because it does not require a cycle ergometer or treadmill, or space for shuttle and walking tests. The patients found it easy to learn the marching movements and rapidly adopted a pace that suited them and could be reproduced with the help of a metronome. The test provided repeatable physiological and perceptual responses as indicated by the low variance of the data in Figure 4 .
The primary outcome measure was of dyspnea assessed with the Borg CR10 scale, which is reported as a valid, reliable, and responsive measures of dyspnea during exercise (Mahler & Horowitz, 1994) and is recommended for cardiopulmonary exercise testing by the American Thoracic Society and American College of Chest
Physicians (2003).
The cross-over design used is suitable for studies looking at the acute effects of an intervention in conditions, such as COPD, where there may be marked differences in pathology between subjects so they act as their own control. One potential problem of a cross-over design is carry-over of the treatment effect, but in the present study, this was minimized by allowing recovery between intervention trials that was many times longer than the time it took for the outcome measures of heart rate, dyspnea, P ET CO 2 , and SpO 2 to return to baseline (Figure 4 ). Although the patients undertook five to six exercise tests, the 2-day interval between visits ensured that potential confounding factors, such as muscle fatigue or raised body temperature, were avoided.
The recovery of dyspnea was somewhat faster in the present study compared with that of Martin and Davenport (2011) , which may reflect the fact that the present patients had less severe respiratory disease and lower Borg CR10 scores at the end of exercise, despite having comparable final heart rates. All the participants, irrespective of the extent of dynamic hyperinflation or the increase in IC following the intervention, reported a faster recovery of dyspnea following the PEP breathing, the recovery times being approximately half those seen after the Sham intervention (Figure 4a ).
Although Martin and Davenport used a PEP of 10-cm H 2 O, the 5-cm H 2 O used here was highly effective; not only did PEP reduce the hyperinflation resulting from the exercise, but also it improved IC relative to the resting condition by, on average, 130 ml ( Figure 5a ).
The median decrease in IC (210 ml) at the end of exercise was towards the lower end of values previously reported during exercise of COPD patients (Frisk et al., 2014) , although the comparison is not strictly relevant because the end point in the Frisk study was maximal exercise whereas in the present study exercise was limited to approximately 70% of maximum heart rate. Nevertheless, three of the present participants had a decrease in IC of 400 ml, or more, and thus would be classified as patients with lung hyperinflation (Frisk et al., 2014) How PEP breathing reduces dyspnea in patients with modest hyperinflation remains unclear, but it is possible that the sensation of breathlessness is sensitive to the change in IC rather than the absolute level of hyperinflation because it was the change in IC that differed significantly between the Sham and PEP interventions (Figure 5b) , rather than the absolute levels (Figure 5a ).
| Limitations
There was a relatively small number of patients, but the two critical outcome measures, dyspnea and IC, showed large and highly significant differences between the two interventions, and it is unlikely that a different result would have been obtained with a larger sample size.
The study was not blinded, something that is almost impossible to do with trials of this type, but the patients were told they were participating in a trial of two treatments, both of which were expected to have some benefits, as was the case as far as changes in IC were concerned.
The Control Visit 4 was not included in the statistical analyses, but in any future trials, it would be useful to include a Control arm in the design. Only male patients volunteered to participate, but we have no reason to believe that women would respond to PEP breathing in any different way.
In conclusion, the results confirm that breathing with a simple PEP device is very effective in reducing exercise-induced dyspnea in COPD patients, significantly shortening the recovery time. The beneficial effects are associated with reductions in hyperinflation, but there was no simple relationship between the magnitude of dynamic hyperinflation and dyspnea. The results indicate that PEP breathing could benefit a wide range of COPD patients, rather than being limited to those who have substantial lung hyperinflation, and could be incorporated into pulmonary rehabilitation programmes as well as being used at home and work to increase the amount of physical activity patients are able to achieve.
| Implications for physiotherapy practice
• Exercise is a key component of pulmonary rehabilitation for COPD patients but dyspnea, or fear of dyspnea, often limits their activity.
• This study has shown that PEP breathing can speed the recovery of postexertional dyspnea in COPD patients and reduce dynamic hyperinflation.
• The effect was not limited to patients with high levels of dynamic hyperinflation. The method could safely be used to increase the volume of exercise during pulmonary rehabilitation sessions and increase physical activity at home and at work.
